These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29555084)

  • 21. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
    Xie P; Zeng X; Xiao J; Sun B; Yang D
    Biochim Biophys Acta; 2014 Dec; 1841(12):1683-90. PubMed ID: 25178844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triacetyl-3-hydroxyphenyladenosine, a derivative of cordycepin, attenuates atherosclerosis in apolipoprotein E-knockout mice.
    Zhao Z; Song G; Tian H; Yu Y; Tian X; Liu J; Yao S; Luo T; Qin S
    Exp Biol Med (Maywood); 2012 Nov; 237(11):1262-72. PubMed ID: 23239437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport.
    Chen X; Tang K; Peng Y; Xu X
    Can J Physiol Pharmacol; 2018 Jan; 96(1):8-17. PubMed ID: 28863273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
    Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
    Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages.
    Hong YF; Kim H; Kim HS; Park WJ; Kim JY; Chung DK
    PLoS One; 2016; 11(4):e0154302. PubMed ID: 27120199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIBP protects against metabolic abnormalities and atherosclerosis.
    Schneider DA; Choi SH; Agatisa-Boyle C; Zhu L; Kim J; Pattison J; Sears DD; Gordts PLSM; Fang L; Miller YI
    J Lipid Res; 2018 May; 59(5):854-863. PubMed ID: 29559522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
    Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
    Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
    Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
    Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
    Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
    Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE
    Qian L; Ma L; Wu G; Yu Q; Lin H; Ying Q; Wen D; Gao C
    Vascul Pharmacol; 2017 Feb; 89():49-57. PubMed ID: 28069546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development.
    Lammers B; Out R; Hildebrand RB; Quinn CM; Williamson D; Hoekstra M; Meurs I; Van Berkel TJ; Jessup W; Van Eck M
    Atherosclerosis; 2009 Aug; 205(2):420-6. PubMed ID: 19217108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quercetin improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice fed a high-fat diet.
    Cui Y; Hou P; Li F; Liu Q; Qin S; Zhou G; Xu X; Si Y; Guo S
    Lipids Health Dis; 2017 Jan; 16(1):9. PubMed ID: 28088205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
    Wu N; Li RQ; Li L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.